Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine
- PMID: 20196181
- DOI: 10.1002/hup.1099
Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine
Abstract
Objective: To explore the association of brain-derived neurotrophic-factor (BDNF) Val66Met polymorphism with both baseline health related quality of life (HRQOL) scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.
Methods: Patients with major depressive disorder (MDD) took fluoxetine (20 mg/day) for 6 weeks. The HRQOL was measured with the Medical Outcomes Study Short Form-36 (SF-36) at baseline and at 6th week. Patients were genotyped for Val66Met polymorphism of BDNF gene.
Results: There was a significant association between social function (SF) and BDNF Val66Met polymorphism, and patients with Met/Met genotype had better SF (compared with Val/Val P = 0.004; compared with Val/Met P = 0.005). A significant association was found between improvement in SF and BDNF Val66Met polymorphism, and patients with Met/Met genotype had poorer improvement in SF (compared with Val/Val P = 0.010; compared with Val/Met P = 0.001). Similar association was found between improvement in mental component summary (MCS) and BDNF Val66Met polymorphism, and patients with Met/Met genotype had poorer improvement in MCS (compared with Val/Val P = 0.066; compared with Val/Met P = 0.006).
Conclusions: These results indicate that there may be association between BDNF Val66Met polymorphism and both baseline HRQOL (SF) scores and improvement in HRQOL (SF, MCS) scores in Chinese major depressive patients treated with fluoxetine.
Copyright 2010 John Wiley & Sons, Ltd.
Similar articles
-
Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.Neuropsychobiology. 2010;61(2):71-8. doi: 10.1159/000265132. Epub 2009 Dec 12. Neuropsychobiology. 2010. PMID: 20016225
-
Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.Psychoneuroendocrinology. 2024 Jul;165:107045. doi: 10.1016/j.psyneuen.2024.107045. Epub 2024 Apr 6. Psychoneuroendocrinology. 2024. PMID: 38636352 Clinical Trial.
-
Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.J Affect Disord. 2015 Apr 1;175:233-40. doi: 10.1016/j.jad.2015.01.013. Epub 2015 Jan 21. J Affect Disord. 2015. PMID: 25658497 Clinical Trial.
-
The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.J Affect Disord. 2019 Jan 15;243:552-558. doi: 10.1016/j.jad.2018.07.054. Epub 2018 Jul 24. J Affect Disord. 2019. PMID: 30078664 Review.
-
Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis.Asia Pac Psychiatry. 2014 Sep;6(3):241-51. doi: 10.1111/appy.12148. Epub 2014 Sep 18. Asia Pac Psychiatry. 2014. PMID: 25231750 Review.
Cited by
-
The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment Response Phenotypes.Int J Mol Sci. 2023 Apr 4;24(7):6758. doi: 10.3390/ijms24076758. Int J Mol Sci. 2023. PMID: 37047730 Free PMC article.
-
NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar Disorder.Front Genet. 2020 Aug 25;11:936. doi: 10.3389/fgene.2020.00936. eCollection 2020. Front Genet. 2020. PMID: 33193575 Free PMC article.
-
Copy number variations and polymorphisms in HSP90AB1 and risk of systemic lupus erythematosus and efficacy of glucocorticoids.J Cell Mol Med. 2019 Aug;23(8):5340-5348. doi: 10.1111/jcmm.14410. Epub 2019 May 24. J Cell Mol Med. 2019. PMID: 31124601 Free PMC article.
-
Associations of HSP90AA2 gene polymorphisms with disease susceptibility, glucocorticoids efficacy and health-related quality of life in Chinese systemic lupus erythematosus patients.Genes Genomics. 2018 Oct;40(10):1069-1079. doi: 10.1007/s13258-018-0714-0. Epub 2018 Jun 15. Genes Genomics. 2018. PMID: 29907909
-
Association of Serotonin 1A Receptor Polymorphism with Variation in Health-Related Quality of Life in Korean Hemodialysis Patients.Psychiatry Investig. 2017 Jul;14(4):506-512. doi: 10.4306/pi.2017.14.4.506. Epub 2017 Jul 11. Psychiatry Investig. 2017. PMID: 28845179 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous